Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

BACKGROUND: Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed intervals between primary debulking surgery and adjuvant chemotherapy was report...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Ovarian Res
Main Authors: Jeong, Soo Young, Choi, Chel Hun, Kim, Tae Joong, Lee, Jeong Won, Kim, Byoung-Gie, Bae, Duk Soo, Lee, Yoo-Young
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937657/
https://ncbi.nlm.nih.gov/pubmed/31892329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-019-0602-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki